Short-chain fatty acid supplement for kidney transplant patients
Part of Digestive system, Hormones & metabolism, Immune system & allergy, Kidney & urinary clinical trials.
This study tests whether taking a short-chain fatty acid (a type of fiber-like substance) supplement can improve gut health in people who have had a kidney transplant. It may help keep the transplant working well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You received a kidney transplant at least 6 months ago
- Your kidney function is stable (eGFR at least 30)
- You haven't had any transplant rejection in the last 6 months
- You have been on the same anti-rejection medicines for at least 3 months
- You are willing to give stool, urine, and blood samples at certain times
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how short-chain fatty acids (compounds made when gut bacteria digest fiber) affect metabolism in healthy people. It may help researchers understand how these natural substances can improve health.
This trial studies whether taking probiotics can help reduce diarrhea caused by immunosuppressive drugs in people who have had a kidney transplant. It may help improve your quality of life after transplant.
This study looks at whether a special diet can help restore good bacteria in your gut after you receive a fecal transplant (a procedure that puts healthy bacteria from a donor into your gut). You'll be asked to take capsules or receive a transplant, and some participants will follow a certain diet to see if it improves gut health.
This trial tests whether taking a probiotic supplement helps people recovering from a kidney transplant. If you are between 18 and 75 years old and had a smooth recovery in the first month after surgery, you may be able to join.
This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.
This trial tests whether transplanting healthy gut bacteria (from donor stool) can improve outcomes in people with cirrhosis. If you have mild to moderate cirrhosis, you may be able to join.
Hear when a new Metabolic Effects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.